Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimized tPA dosing guided by artery status in acute ischemic stroke
2008-003371-53Phase 3Completed
- Sponsor
- St. Anne's University Hospital Brno
- Start
- Jul 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of tissue-plasminogen activator in ischemic stroke, sponsored by St. Anne's University Hospital Brno. Primary endpoints: Symptomatic intracerebral hemorrhage and Complete recanalization. Started Jul 2008; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on 2008-003371-53.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003371-53.